Want To Know the No.1 Crypto and the No.1 Stock?

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

Ondas Holdings Stock Is Hitting New 52-Week Highs Today: Here's Why

Alex Perry
October 02, 2025

Shares of Ondas Holdings Inc. (NASDAQ:ONDS) are soaring Thursday after the autonomous drone infrastructure company said it placed a significant purchase order.

What To Know: Ondas announced that it placed its initial order of 500 WÃ¥sp drones from Rift Dynamics, a Norwegian drone company, to launch U.S. defense market distribution through its American Robotics subsidiary.

The WÃ¥sp is combat-ready drone designed to meet growing demand from the U.S.’s recently renamed Department of War (DOW), previously called the Department of Defense, for “mass affordable” strike and perimeter defense platforms.

“Demand from the U.S. Department of War and allied defense forces for mass-affordable attritable platforms is accelerating, and the WÃ¥sp is engineered to meet that requirement,” Ondas CEO Eric Brock said.

“Leveraging Rift’s NDAA-compliant design and Kitron proven global manufacturing expertise, Ondas is able [to] rapidly scale production and deliver thousands of units per month.”

Kitron, a defense manufacturer based in the U.S., will be in charge of producing the initial 500 drones. The total will eventually scale to more than 20,000 units per month within six months. Ondas is actively pursuing contracts with the DOW and said it expects to receive its initial deliveries of WÃ¥sp systems in the fourth quarter of 2025.

“We are thrilled Rift Dynamics has chosen Kitron as a manufacturing partner to support its growth and we are well positioned to meet that demand,” said Gary Tarallo, Kitron’s managing director of US Operations.

ONDS Price Action: Ondas shares were up 25.65% at $9.18 at the time of publication on Thursday, according to Benzinga Pro. Ondas stock is making new 52-week highs on Thursday.

Read More:

  • From AI To Delivery Drones: Defiance’s JEDI ETF Targets Next-Gen Autonomy

Image: Drone-Photo/Shutterstock.com

Continue Reading...

Popular

Donald Trump's Approval Rating Crashes to Record Low — Here's What's Driving the Decline

According to the recent YouGov/Economist poll, President Trump's approval rating has taken a nosedive, reaching its lowest point in his second term.

Cathie Wood Dumps $5.2 Million Worth of This AI Stock, Here's What Ark Bought Instead

Ark Invest decided to sell shares of Tempus AI (TEM), despite positive news of FDA clearance for its diagnostic device. They also made other key trades.

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

Nebius Vs. Palantir: The AI Infrastructure War At 100x Sales

Wall Street's AI mania has sparked a battle between Nebius (NBIS) and Palantir (PLTR) as investors question where the true value of AI lies.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Harvard Business School graduate arrested on charges he cheated fellow alums out of over $4 million

NEW YORK (AP) — A Harvard Business School graduate was arrested Thursday on fraud charges alleging he swindled fellow alumni of the prestigious school out of over $4 million in a Ponzi scheme, even assuring one investor they would soon “brag” about their “crazy gains” at the school's reunion.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Scam centers are spreading in East Timor, UN report says

BANGKOK (AP) — A suspected scam call operation and a suspicious network of companies was discovered with links to a new free trade zone in East Timor, the U.N. Office of Drugs and Crime said Thursday.

Opendoor Is A 'Stock That Could Be The Amazon Of Housing': Eric Jackson

Eric Jackson sees Opendoor as able to simplify the experience of buying and selling a home in the same way that Amazon revolutionized retail.

Rare Disease Biotech Offers Access Ahead of Key Milestone - Ad

This late-stage biotech is gearing up for Phase 2 trials with an FDA-designated orphan drug. It's already drawing comparisons to recent billion-dollar exits. Backed by a proven biotech incubator, it's now offering early access to its raise.

Canada's Carney heads to Mexico to discuss trade before a review of their US trade deal

TORONTO (AP) — Canadian Prime Minister Mark Carney heads to Mexico on Thursday in an effort to diversify trade as America’s neighbors brace for a review of the free trade deal with United States.

Time to Say Goodbye to "Old" Dollar? Say Hello to "Trump's New Dollar" - Ad

If you have any money in U.S. dollars... learn how to prepare for "Trump's new dollar"... Because this could be the biggest change to our financial system in 54 years. President Trump even called it: "The greatest revolution in financial technology since the birth of the internet itself."

US jobless aid applications retreat to 231,000 after surging to nearly 4-year high a week earlier

The number of Americans applying for jobless aid last week retreated significantly after surging to a nearly four-year high a week earlier.

Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients

Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients.

The "Mar-A-Lago Accord" Is Now Underway - Ad

The global order is in chaos. And according to 40-year market veteran Dr. David Eifrig, the biggest controlled demolition of the old monetary order in history could now be here, too. That means if you don't take action today, your wealth could decline by 40%... (Yes, even your cash savings.)

Ticket marketplace StubHub to see if its stock is the right price for Wall Street

NEW YORK (AP) — StubHub is set to enter the public arena Wednesday after the ticket marketplace priced its initial public offering at $23.50 per share.

New York City's Wealthiest Neighborhoods Witness 60% Rent Surge Since Pandemic

House rental rates in some of the wealthiest neighborhoods of New York City have surged by over 60% since the COVID-19 pandemic began, putting even high-income earners in a tight spot.

The Tesla Shock Nobody Sees Coming - Ad

While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as October 23rd.

AquaBounty Technologies Stock Explodes Over 98% After Hours: Here's Why

AquaBounty Technologies saw a massive 98.25% surge in after-hours trading to $2.26, following confirmation that it had met NASDAQ's minimum bid price requirement, resolving its earlier delisting risk.

Apple's iPhone 17 Series Takes Off, Meta's New Smart Glasses And Major Partnerships In AI Space: This Week In AI

This weekend's tech roundup featured Apple's strong iPhone 17 launch in China and India, Meta's new smart glasses, major AI partnerships like Intel-Nvidia and PayPal-Google, and Jim Cramer questioning Huawei's chip breakthrough.

Elon's $25 Trillion Confession - Ad

Elon Musk: "Tesla will become a $25 trillion company." That would make Tesla 8x bigger than Apple today. How is that possible? He admits it's all thanks to this one AI breakthrough that will take AI out of our computer screens and manifest a 250x boom here in the real world.

Lyft Finds Its Robotaxi Mojo—But Uber's Still In The Fast Lane

Lyft scores a 10% stock pop on its first robotaxi deal with Alphabet's Waymo. But can it compete with Uber's global reach and dominance?

Jerome Powell and Economists Agree: Gen Z Faces a Hiring Crisis And That's Not About AI

In 2025, the rising unemployment rate among Americans under 25, specifically recent graduates, has become a significant economic concern.

Why This Crypto Skeptic Had a Change of Heart - Ad

He used to make fun of crypto. Now... he says one $3 crypto could rise to $92 by next year.

Lockheed Martin Counters Boeing's F-47 Victory With Cost-Effective F-35 Upgrade Using Sixth-Gen Technology

Lockheed Martin is countering Boeing's F-47 win with a cost-effective F-35 upgrade that integrates sixth-generation tech, aiming to offer 80% of the F-47's capabilities at half the price.

‘Race against time’ to remove rubble after recent earthquake in Afghanistan’s east, says UN

The United Nations says aid workers are still in a “race against time” to remove rubble and rebuild after the eastern Afghanistan last month, killing at least 2,200 people and cutting off remote areas.

Want To Know the No.1 Crypto and the No.1 Stock? - Ad

The #1 crypto is just $3. Crypto analysts say a cash injection could drive it as high as $100 in the next year. The #1 stock is equally exciting. It's less than $10 but made a HUGE deal recently to work with Nvidia.

US orders Delta and Aeromexico to dissolve their partnership over fairness concerns in Mexico

U.S. Transportation Secretary Sean Duffy is following through on to force Delta and Aeromexico to dissolve their longtime partnership because of his concerns that Mexico isn't being fair to U.S. airlines.

How the Multiplier Effect is Working on This $3 Crypto - Ad

It's called the multiplier effect in crypto. In short, because of a lack of supply, small inflows of cash can create major moves in the overall value of the crypto. And it's particularly strong in one $3 crypto. Crypto analysts are suggesting it could rise to as high as $100 by next year.

Trump Admin's Intel Stake Could Create 'Unintended Inefficiencies' In Global Chip Industry, Warns Fitch

The U.S. government's recent investment in Intel Corp. (NASDAQ: INTC) could lead to unintended inefficiencies in the global semiconductor industry, according to a report by Fitch Ratings.

Biotech With Multiple Orphan Drugs Is Quietly Opening Its Doors - Ad

A promising biotech developing treatments for rare childhood brain diseases is opening a new raise. Its lead drug has fast-track status, orphan designations, is nearing Phase 2 and backed by a Global Integrator.

Fed convenes meeting with a governor newly appointed by Trump and another he wants to oust

WASHINGTON (AP) — After a and the Federal Reserve began a key meeting on interest rate policy Tuesday with both a new Trump administration appointee and an official the White House has targeted for removal.

Judge Tosses Trump's $15 Billion Case Against New York Times, President Claims He's 'Winning'

A federal judge dismissed Trump's $15 billion defamation lawsuit against The New York Times, calling it "decidedly improper," but gave him 28 days to resubmit it with a 40-page limit.

New Biotech Offering Targets $426B Rare Disease Market - Ad

The rare disease drug space is growing fast-and so is investor interest. With exclusivity, pricing power and major M&A moves, the rare disease space is getting interesting. This company has the science and the experience.

Why Redwire Stock Is Gaining Today

Redwire climbs about 4% after subsidiary Edge Autonomy wins a European NATO ally contract to supply Stalker Group 2 reconnaissance drone.

Trending Now

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright traderelite.club
Privacy Policy | Terms of Service